Core and Group Health

Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's doing any good, a new study says.

Lawmakers gave final approval Wednesday to legislation that would expand the type of ailments covered by the state workers' compensation system, a move that supporters hope will make Missouri more attractive to businesses by lessening their potential litigation costs.

Those in the health care industry are becoming more and more tech-savvy.

The final rule of U.S. Health and Human Services on affordable insurance exchanges is expected out this month, with reports that it can be as soon as this week or by the end of the month.

Eight drugmakers are being sued by a consumer advocacy group that alleges their programs offering coupons to reduce copayments for brand-name medicines are illegal.

Federal prosecutors have asked a judge to approve an antitrust settlement involving two Montana health insurers now that one of the companies has been broken up as part of the deal.